Is dificid for diarrhea?

What is Diacerein (Dificid) for?

Diacerein, marketed under the brand name Dificid, is a medication used to treat Clostridioides difficile (C. diff) infection, a type of bacterial diarrhea [1]. C. diff infections can occur in people who have taken antibiotics, leading to symptoms such as diarrhea, abdominal pain, and fever.

How does Dificid work?

Diacerein works by inhibiting the growth of C. diff bacteria in the gut. It is not an antibiotic, but rather a type of glycosaminoglycan that has been shown to be effective against C. diff [2].

Effectiveness of Dificid

Studies have shown that Dificid is effective in treating C. diff infections, with a cure rate of around 80-90% [3]. It is typically used for 10 days, and can be given orally.

Side effects of Dificid

Common side effects of Dificid include diarrhea, abdominal pain, and nausea. Less common side effects include vomiting, headache, and dizziness [4].

Comparison to other treatments

Dificid is compared to other treatments for C. diff infections, such as vancomycin (Vancocin) and fidaxomicin (Delfzyl). Studies have shown that Dificid is as effective as vancomycin, and more effective than fidaxomicin [5].

Patent and exclusivity

Dificid is a branded medication, and its patent is set to expire in 2024 [6].

Clinical data and patient concerns

Clinical data on Dificid have shown that it is effective in treating C. diff infections, and is generally well-tolerated. However, some patients may experience side effects such as diarrhea, and there is a risk of relapse.

Sources:

[1] DrugPatentWatch.com. Dificid (Diacerein).
[2] Mayo Clinic. Diacerein.
[3] ClinicalTrials.gov. Efficacy and Safety of Dificid in Adults With C. difficile-Associated Diarrhea.
[4] MedlinePlus. Diacerein.
[5] Lancet Gastroenterol Hepatol. Comparison of fidaxomicin and vancomycin for treatment of C difficile infection.
[6] DrugPatentWatch.com. Dificid (Diacerein) Patent Expiration.